Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. engages in the provision of clinical research, medical communications, consulting, commercialization and informatics, and technology services to pharmaceutical, biotechnology, and medical device industries.

It operates through the following segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics.

The Clinical Research Services segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, date management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, clinical pharmacology, and related medical affairs, patient recruitment and investigator site services.

The PAREXEL Consulting Services segment provides technical expertise and advice in drug development, regulatory affairs, and good manufacturing practice compliance consulting.

The PAREXEL Informatics segment provides information technology solutions designed to improve client's product development processes.

The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.

Number of employees : 18 600 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Clinical Research Services1,53565.8%1,62667% +5.9%
PAREXEL Informatics264.6711.3%277.9011.4% +5%
PAREXEL Consulting Services215.959.3%190.407.8% -11.83%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States984.6842.2%908.9037.4% -7.7%
Europe, Middle East & Africa451.4619.4%568.1023.4% +25.84%
Asia/Pacific269.3011.5%296.7012.2% +10.18%
United Kingdom239.6510.3%251.0010.3% +4.74%
Americas70.903%69.602.9% -1.83%
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA621983Chairman & Chief Executive Officer
Mark A. Goldberg, MD561997President & Chief Operating Officer
Emma Reeve562014Chief Financial Officer & Vice President
Sy Pretorius MD, MBA--Chief Scientific Officer & Vice President
A. Dana Callow Jr., MBA651986Independent Director
Patrick J. Fortune PhD, MBA701996Independent Director
Richard L. Love732002Independent Director
Ellen M. Zane652006Independent Director
Eduard Enrico Holdener, MD712008Independent Director
May-Kin Ho, PhD642015Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 50,762,287 49,756,028 98.0% 0 0.0% 98.0%
Shareholders
NameEquities%
BlackRock Fund Advisors 5,031,259 9.87%
The Vanguard Group, Inc. 4,166,264 8.18%
Morgan Stanley & Co. LLC 2,521,789 4.95%
Fisher Asset Management LLC 2,160,308 4.24%
Credit Suisse Securities (USA) LLC (Broker) 2,093,297 4.11%
Starboard Value LP 1,995,460 3.92%
SSgA Funds Management, Inc. 1,673,118 3.28%
Nomura Securities Co., Ltd. (Private Banking) 1,381,087 2.71%
Wellington Management Co. LLP 1,136,930 2.23%
ClearBridge Investments LLC 1,118,312 2.19%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PAREXEL INTERNATIONAL ..21.18%4 026
INCYTE CORPORATION35.79%27 528
QUINTILES IMS HOLDINGS..9.85%18 382
LONZA GROUP AG18.67%15 234
CELLTRION, INC.--.--%10 254
SEATTLE GENETICS, INC.26.04%9 492
ALKERMES PLC4.93%8 934
QIAGEN NV12.55%7 527
ALNYLAM PHARMACEUTICAL..97.46%6 372
IONIS PHARMACEUTICALS ..-6.42%5 549
UNITED THERAPEUTICS CO..-14.54%5 523
ICON PLC18.28%4 810
PRA HEALTH SCIENCES IN..29.48%4 440
GALAPAGOS26.57%4 344
CHARLES RIVER LABORATO..18.94%4 306
BIO-TECHNE CORP7.30%4 119
EXACT SCIENCES CORPORA..138.77%3 536
ACADIA PHARMACEUTICALS..-4.47%3 419
BB BIOTECH AG-0.36%3 125
INC RESEARCH HOLDINGS ..5.89%3 041
NEKTAR THERAPEUTICS60.96%2 991
Sector Biotechnology & Medical Research - NEC
PAREXEL International Corp : Connections
Harvard T.H. Chan School of Public Health
MedAptus, Inc.
Molecular Profiling Institute, Inc.
Tufts University
Applied Microarrays, Inc.
Jobs for Massachusetts, Inc.
PHT Technologies, Inc.
Caris Molecular Profiling Institute, Inc.
The Leukemia & Lymphoma Society, Inc.
TVP Management Co. LLC
The Floating Hospital, Inc.
Center For Private Equity & Entrepreneurship
Boston Millennia Partners III LP
George Washington University
Tufts University School of Medicine
CardioMEMS LLC
Epigenesis Pharmaceuticals LLC
Ascalon International, Inc.
Sapphire Therapeutics, Inc.
Syndevrx, Inc.
University of Wisconsin Foundation
PMed Management LLC
University of Illinois
Translational Accelerator LLC
Sun Mountain Capital LLC
Minuteman Health, Inc.
Ascalon Pharmaceuticals
Tufts Medical Center, Inc.
CerRx, Inc.
Press Ganey Associates, Inc.
Cancer Prevention Pharmaceuticals Inc
Agnovos Healthcare LLC
The Aaron Diamond AIDS Research Center
PAREXEL International Ltd.
Swiss Cancer Foundation
New England Healthcare Institute
MedTrust Online LLC
Viridian Global Logistics, Inc.
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2017 People , Fundamentals and Ownership